LFG
COGT icon

Larson Financial Group’s Cogent Biosciences COGT Stock Holding History

Larson Financial Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9K Hold
75
– – ﹤0.01% 2994
2026
Q1 		$2.89K Hold
75
– – ﹤0.01% 2849
2025
Q4 		$2.66K Sell
75
-178
-70% -$5K ﹤0.01% 2702
2025
Q3 		$3.63K Buy
+253
New +$3K ﹤0.01% 2476
2025
Q2 		– Sell
-16
Closed -$96 – 3328
2025
Q1 		$96 Buy
+16
New +$125 ﹤0.01% 2917

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Larson Financial Group's COGT Position: Q2 2026 in Review

Larson Financial Group held its Cogent Biosciences (COGT) position steady in Q2 2026 at 75 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2994.

Larson Financial Group first reported a position in COGT in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.63K in Q3 2025. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Larson Financial Group held 75 shares of Cogent Biosciences worth $2.9K as of Q2 2026.
  • Larson Financial Group left its Cogent Biosciences share count unchanged in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2994 holding.
  • Larson Financial Group first reported a position in Cogent Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Larson Financial Group's Cogent Biosciences position peaked at $3.63K in Q3 2025.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.